(L.A.) Kenisha Reyes, 33, Died at a Residence

Case Number: 2023-12743

Los Angeles County is reporting the death of a 33-year-old Asian that occurred at her residence.

The coroner’s office has identified the person as Kenisha Reyes.

Born in L.A. County. Mother’s maiden name is Garcia.

Manner of Death: Natural

Cause of Death A: Multiple Organ Failure

Cause of Death B: Budd-Chiari Syndrome

Other Significant Condition: End-Stage Renal Disease

RIP KENISHA MARIE REYES (March 22, 1990 – September 4, 2023)

Formal pronouncement of death was made on Monday at 10:15 p.m.

The decedent may have been of Filipino descent. We do not know if she was injected with synthetic mRNA.

Budd–Chiari syndrome is a very rare condition, affecting one in a million adults. The condition is caused by occlusion of the hepatic veins (usually due to a blood clot) that drain the liver. The symptoms are non-specific and vary widely, but it may present with the classical triad of abdominal pain, ascites, and liver enlargement. It is usually seen in younger adults, with the median age at diagnosis between the ages of 35 and 40, and it has a similar incidence in males and females. The syndrome can be fulminant, acute, chronic, or asymptomatic.

CASE REPORT FROM SOUTH KOREA

A newly diagnosed Budd-Chiari Syndrome with thrombotic thrombocytopenia after BTN162b2 vaccination

ncbi.nlm.nih.gov/pmc/articles/PMC9115202/

Worldwide, Pfizer/BioNTech (BTN162b2) mRNA vaccine is now under massive use to be protected from COVID-19, although it may cause thrombotic thrombocytopenia in rare cases. Budd-Chiari syndrome (BCS) is a rare condition and is defined as the obstruction of hepatic venous outflow.

A 34-year-old woman who was vaccinated with first dose of BTN162b2 six weeks ago newly developed ascites, liver dysfunction, and thrombocytopenia.

Contrast-enhanced CT scan, doppler ultrasound, and hepatic venography showed complete obstruction of three major hepatic veins without membranous structure and without any collaterals, causing portal hypertension and liver dysfunction. Percutaneous liver biopsy showed diffusion dilation of sinusoids with extensive hepatocyte dropout, although there was no portal inflammation or fibrosis. The patient was treated with anticoagulants and intravenous immunoglobulin. After 6 weeks of anticoagulation, hepatic venous outflow became well detectable by doppler ultrasonography and ascites disappeared.

This is a rare case of acute BCS with thrombotic thrombocytopenia after BNT162b2 mRNA vaccination.

pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1995909